Noxamet Overview
- Year Founded
-
2010
- Status
-
Out of Business
- Employees
-
2
- Latest Deal Type
-
Out of Business
Noxamet General Information
Description
Manufacturer of chemical compounds intended for preclinical development of new vasodilating and endothelium-protective drugs to be primarily used in the treatment of cardiovascular diseases. The company focuses on a proprietary class of molecules that act as controlled nitric oxide donors, carries out design, synthesis, and physicochemical characterization activities, enabling healthcare and life sciences stakeholders to translate university research into development-ready drug candidates while also offering potential collaborations on new drugs, medical devices
Contact Information
Website
www.noxamet.euCorporate Office
- Via Enrico Besana, 2
- 20122 Milan(Lombardy)
- Italy
Corporate Office
- Via Enrico Besana, 2
- 20122 Milan(Lombardy)
- Italy
Noxamet Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 24-Feb-2026 | Completed | Out of Business | |||
| 2. Accelerator/Incubator | 01-Oct-2021 | Completed | Stealth | |||
| 1. University Spin-Out | 01-Jul-2010 | Completed | Stealth |
Noxamet Signals
Noxamet FAQs
-
When was Noxamet founded?
Noxamet was founded in 2010.
-
Where is Noxamet headquartered?
Noxamet is headquartered in Milan, Italy.
-
What is the size of Noxamet?
Noxamet has 2 total employees.
-
What industry is Noxamet in?
Noxamet’s primary industry is Drug Discovery.
-
Is Noxamet a private or public company?
Noxamet is a Private company.
-
What is Noxamet’s current revenue?
The current revenue for Noxamet is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process